Skip to content
← All settings

DISEASE & TREATMENT SETTING

Malignant Fallopian Tube Neoplasm

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Malignant Fallopian Tube Neoplasm

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 58 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      30 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00262847 · Source cited / selected · Scope: narrower

      Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

      4 outcome links · 3 safety-group records · 1 quality-of-life measures

      →

      NCT00301756 · Registry condition search · Scope: narrower

      Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00381888 · Registry condition search · Scope: narrower

      Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

      2 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00390234 · Registry condition search · Scope: narrower

      Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00505661 · Registry condition search · Scope: narrower

      Letrozole in Patients With Ovarian Tumors

      1 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00565851 · Source cited / selected · Scope: narrower

      Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fall

      6 outcome links · 8 safety-group records · 4 quality-of-life measures

      →

      NCT00652899 · Registry condition search · Scope: narrower

      Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00870233 · Registry condition search · Scope: narrower

      Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life

      4 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT00954174 · Registry condition search · Scope: narrower

      Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

      6 outcome links · 2 safety-group records · 4 quality-of-life measures

      →

      NCT01010126 · Registry condition search · Scope: narrower

      Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

      6 outcome links · 6 safety-group records · 0 quality-of-life measures

      →

      NCT01079832 · Registry condition search · Scope: narrower

      Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

      5 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT01081262 · Registry condition search · Scope: narrower

      Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stag

      6 outcome links · 4 safety-group records · 2 quality-of-life measures

      →

      NCT01167712 · Source cited / selected · Scope: narrower

      Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian

      4 outcome links · 2 safety-group records · 1 quality-of-life measures

      →

      NCT01891344 · Source cited / selected · Scope: narrower

      A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01968213 · Source cited / selected · Scope: narrower

      Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

      6 outcome links · 2 safety-group records · 2 quality-of-life measures

      →

      NCT02122185 · Registry condition search · Scope: narrower

      Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02142803 · Registry condition search · Scope: narrower

      TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

      6 outcome links · 3 safety-group records · 1 quality-of-life measures

      →

      NCT02283658 · Registry condition search · Scope: narrower

      Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT02631876 · Source cited / selected · Scope: narrower

      A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary P

      6 outcome links · 2 safety-group records · 1 quality-of-life measures

      →

      NCT02650986 · Registry condition search · Scope: narrower

      Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

      5 outcome links · 4 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-malignant-fallopian-tube-neoplasm
        binding id
        ncit-C7480
        source collection
        ncit-concept
        source key
        C7480
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice